跳至主要内容
临床试验/CTRI/2023/06/053807
CTRI/2023/06/053807尚未招募Unknown

Cariprazine as adjunctive treatment in patients with drug resistant obsessive compulsive disorder: A randomized double blind placebo controlled study

Central Institute of Psychiatry0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of either sex, aged between 18- 50 years.
  • 2.Patients fulfilling ICD 10-DCR diagnostic criteria for Obsessive Compulsive Disorder but are drug resistant.
  • 3.Patients giving written informed consent.

排除标准

  • 1.Any other major co-morbid psychiatric diagnoses (except mild to moderate depression, cut off as per HAM-D <18 and mild to moderate anxiety, cut off as per HAM-A <24) and substance dependence excluding nicotine & caffeine.
  • 2.Presence of an acute/unstable medical or neurological condition.
  • 3.Pregnancy or lactation.

研究者

相似试验